Results
|
|
101.
|
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017) [electronic resource] by
- Mulder, J W
- Cooper, D A
- Mathiesen, L
- Sandström, E
- Clumeck, N
- Gatell, J M
- French, M
- Donovan, B
- Gray, F
- Yeo, J M
Producer: 19940816
In:
AIDS (London, England) vol. 8
Availability: No items available.
|
|
|
102.
|
|
|
|
103.
|
|
|
|
104.
|
|
|
|
105.
|
|
|
|
106.
|
|
|
|
107.
|
|
|
|
108.
|
|
|
|
109.
|
|
|
|
110.
|
|
|
|
111.
|
|
|
|
112.
|
|
|
|
113.
|
|
|
|
114.
|
|
|
|
115.
|
|
|
|
116.
|
HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. [electronic resource] by
- Boucher, C A
- Lange, J M
- Miedema, F F
- Weverling, G J
- Koot, M
- Mulder, J W
- Goudsmit, J
- Kellam, P
- Larder, B A
- Tersmette, M
Producer: 19930202
In:
AIDS (London, England) vol. 6
Availability: No items available.
|
|
|
117.
|
|
|
|
118.
|
|
|
|
119.
|
|
|
|
120.
|
|